20 LATEST RESOURCES (404 INDEXED)
Donepezil for Dementia with Lewy Bodies: Meta-Analysis of Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase II, III, and, IV Studies · March 2024
Articles
Psychogeriatrics
Effect of High-Frequency (5Hz) rTMS Stimulating Left DLPFC Combined with Galantamine on Cognitive Impairment After Ischemic Stroke and Serum Homocysteine and Neuron-Specific Enolase · February 2024
Articles
Frontiers in Neurology
Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-Analysis · June 2023
Abstracts
JAMA Neurology
Relationship between Antidementia Medication and Fracture Prevention in Patients with Alzheimer’s Dementia Using a Nationwide Health Insurance Claims Database · April 2023
Articles
Scientific Reports
Extemporaneous Combination of Donepezil and Memantine to Treat Dementia in Alzheimer Disease: Evidence from Italian Real-World Data · March 2023
Articles
Current Medical Research and Opinion
Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect Not to Be Underestimated · February 2023
Articles
Annals of Geriatric Medicine and Research
Anti-Dementia Drug Persistence Following Donepezil Initiation among Alzheimer’s Disease Patients in Japan: LIFE Study · November 2022
Articles
Journal of Alzheimer’s Disease
Modulation of Amyloid-B and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin and Donepezil · November 2022
Articles
Journal of Alzheimer’s Disease
Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil · October 2022
Articles
Journal of Alzheimer’s Disease
Efficacy of Methylphenidate for the Treatment of Apathy in Patients with Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Studies · October 2022
Abstracts
Psychopharmacology
Acetyl-Cholinesterase-Inhibitors Slow Cognitive Decline and Decrease Overall Mortality in Older Patients with Dementia · July 2022
Articles
Scientific Reports
Effect of Donepezil for Dementia Prevention in Parkinson’s Disease with Severe Hyposmia (The DASH-PD Study): A Randomized Long-Term Placebo-Controlled Trial · July 2022
Articles
eClinicalMedicine
A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients with Alzheimer’s Disease · June 2022
Articles
Journal of Clinical Neurology
Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease · May 2022
Articles
Journal of Alzheimer’s Disease Reports
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives · April 2022
Articles
Journal of Alzheimer’s Disease Reports
A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer’s Disease · April 2022
Articles
Frontiers in Aging Neuroscience
Long-Term Effect of Acetylcholinesterase Inhibitors on the Dorsal Attention Network of Alzheimer’s Disease Patients: A Pilot Study Using Resting-State Functional Magnetic Resonance Imaging · April 2022
Articles
Frontiers in Aging Neuroscience
Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients with Alzheimer’s Disease: A Nationwide Propensity Score Matching Study · March 2022
Articles
Frontiers in Cardiovascular Medicine